Clinical trials
Lung Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
187 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 11 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 11 |
| 2016 | 9 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 15 |
| 2022 | 15 |
| 2023 | 14 |
| 2024 | 16 |
| 2025 | 16 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
| Recruiting | 46 |
| Unknown status | 38 |
| Active, not recruiting | 22 |
| Terminated | 9 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 36 |
| Novartis Pharmaceuticals | 12 |
| AstraZeneca | 9 |
| Pfizer | 9 |
| Chang Gung Memorial Hospital | 7 |
| Bristol-Myers Squibb | 6 |
| Amgen | 4 |
| Chung Shan Medical University | 4 |
| Eli Lilly and Company | 4 |
| Revolution Medicines, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 187 |
| Carcinoma, Non-Small-Cell Lung | 86 |
| Neoplasms | 24 |
| Carcinoma | 14 |
| Lung Diseases | 14 |
| Neoplasm Metastasis | 12 |
| Neoplasms by Site | 11 |
| Respiratory Tract Diseases | 11 |
| Respiratory Tract Neoplasms | 11 |
| Breast Neoplasms | 10 |
Trials
Showing 26 to 50 of 187. Each trial links to its page on Pharma Observatory.
87 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.